Invention Application
US20120283220A1 ANTOFINE AND CRYPTOPLEURINE DERIVATIVES AS ANTICANCER AGENTS
有权
ANTOFINE和CRYPTOPLEURINE衍生物作为反应剂代理
- Patent Title: ANTOFINE AND CRYPTOPLEURINE DERIVATIVES AS ANTICANCER AGENTS
- Patent Title (中): ANTOFINE和CRYPTOPLEURINE衍生物作为反应剂代理
-
Application No.: US13503113Application Date: 2010-09-22
-
Publication No.: US20120283220A1Publication Date: 2012-11-08
- Inventor: Kuo-Hsiung Lee , Xiaoming Yang , Qian Shi , Kenneth F. Bastow , Che-Ming Teng , Tse-Ming Hong , Pan-Chyr Yang , Shuenn-Chen Yang
- Applicant: Kuo-Hsiung Lee , Xiaoming Yang , Qian Shi , Kenneth F. Bastow , Che-Ming Teng , Tse-Ming Hong , Pan-Chyr Yang , Shuenn-Chen Yang
- International Application: PCT/US10/49780 WO 20100922
- Main IPC: A61K31/4745
- IPC: A61K31/4745 ; A61K31/4985 ; C07F9/6561 ; A61K31/675 ; A61K31/519 ; A61P35/02 ; A61K31/5383 ; A61K31/5365 ; C07D455/03 ; A61K31/55 ; A61P35/00 ; C07D471/04 ; C07D498/04
Abstract:
The present invention provides compounds of Formula (I-IV): compositions containing the same, and methods of use thereof such as for the treatment of cancer.
Public/Granted literature
- US09216977B2 Antofine and cryptopleurine derivatives as anticancer agents Public/Granted day:2015-12-22
Information query
IPC分类:
